Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
This multicentre, double-blind, randomized, placebo-controlled phase 2 study assessed subcutaneous liraglutide (1.8 mg daily) against placebo over 48 weeks
Among these segments, the victoza segment is dominating the market with the largest revenue share during the forecast period
If you notice that the formula has separated, a gentle shake will quickly resolve this
Trial of Lixisenatide in Early Parkinson's Disease
PubMed laboratory research record [PMID: 40663350] PubMed record related to this compound for laboratory literature review
US$ 27.68
US$ 28.64
US$ 25.32
US$ 28.55
US$ 20.19
